Delivery Order SPE2DB20D3101-SPE2DB22FH6E6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,555,366,708 units of Lantus Solostar 100 unit/mL 3mL. The $1,424.64 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lantus Solostar 100 unit/ml 3ml medication. The $2,929.28 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for 4,561,309,731 units of Lantus Solostar 100 unit/mL 3mL. The $1,316.58 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance location in Conshohocken, PA. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant...
- This federal contract award, valued at $1,794.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,781.40, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a prescription medication. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical,...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml to the Defense Logistics Agency (DLA). The $2,440.77 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc., doing business as Amerisourcebergen Drug Corp. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,246.64 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., valued at up to $999,999,999.00, which provides comprehensive pharmaceutical and medical supply support to the Department of Defense and other federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a diabetes medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary vehicle for Cencora to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.80, is a delivery order for the provision of Lantus Solostar 100 Unit/ML 3ML medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has an ultimate completion date of March 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH6E6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus Solostar 100 unit/ml 3ml products. The $1,187.20 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, and this award demonstrates its capacity to efficiently deliver critical pharmaceutical commodities to meet the diverse medical needs of government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/27/22 |